Effect of lymphatic mapping on the new tumor-node-metastasis classification for colorectal cancer.

PURPOSE Sensitive detection methods and accurate reporting are necessary to determine the prognostic significance of micrometastases (MM) and isolated tumor cells (ITCs) in lymph nodes that drain colorectal cancers (CRCs). This study examined the role of lymphatic mapping (LM) in the application of the new tumor-node-metastasis (TNM) classification for MM and ITC. PATIENTS AND METHODS All patients at the John Wayne Cancer Institute underwent LM immediately before standard resection of primary CRC between 1996 and 2001. Sentinel nodes (SNs) were identified using blue dye and/or radiotracer and were examined by hematoxylin-eosin (H&E) staining, cytokeratin immunohistochemistry, and multilevel sectioning. The comparison group comprised 370 patients whose primary CRCs were resected without LM during the same period at the same institution. RESULTS LM was successfully performed in 115 of 120 (96%) patients and correctly predicted the tumor status of the nodal basin in 110 of 115 (96%) patients. Thirty-seven patients (32%) were lymph node-positive by H&E, ITC and MM were found in 23 patients (29.4%) whose lymph nodes were negative by H&E. Tumor deposits were found in the SN only in 29 patients (50%). Nodal involvement was identified for 14.3%, 30%, 74.6%, and 83.3% of T1, T2, T3, and T4 tumors, respectively, in the study group, and for 6.8%, 8.5%, 49.3%, and 41.8% of T1, T2, T3, and T4 tumors, respectively, in the comparison group. The study group had a higher percentage of nodal metastases (53% v 36%; P <.01) and a higher incidence of MM and ITC (29.4% v 1.9%; P <.0001). The mean number of lymph nodes found in the study group (14) was also significantly more than the number found in the comparison group (10; P <.00001). CONCLUSION Conventional examination of lymph nodes for CRC is inadequate for the detection of MM and ITC as described in the new TNM classification. Thus, LM and focused SN analysis should be considered to fully stage CRC.

[1]  F. Cianchi,et al.  Lymph Node Recovery from Colorectal Tumor Specimens:Recommendation for a Minimum Number of Lymph Nodes to be Examined , 2002, World Journal of Surgery.

[2]  S. Hong,et al.  Occurrence and prognostic implications of micrometastases in lymph nodes from patients with submucosal gastric carcinoma , 2002, Annals of Surgical Oncology.

[3]  M. Espinosa,et al.  Ultrastaging of colorectal cancer by sentinel lymph node mapping technique--a multicenter trial. , 2001, Annals of surgical oncology.

[4]  W. Hohenberger,et al.  High‐risk groups of patients with Stage II colon carcinoma , 2001, Cancer.

[5]  T. Namiki,et al.  Ex Vivo Sentinel Node Mapping in Carcinoma of the Colon and Rectum , 2001, Annals of surgery.

[6]  D. Morton,et al.  Validation of Lymphatic Mapping in Colorectal Cancer: In Vivo, Ex Vivo, and Laparoscopic Techniques , 2001, Annals of Surgical Oncology.

[7]  R. Turner,et al.  Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  D. Poller.  Method of specimen fixation and pathological dissection of colorectal cancer influences retrieval of lymph nodes and tumour nodal stage. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[9]  L. Sobin,et al.  Classification of isolated tumor cells and micrometastasis , 2000 .

[10]  Carolyn Compton,et al.  American Joint Committee on Cancer prognostic factors consensus conference , 2000, Cancer.

[11]  R. Elashoff,et al.  Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  T. Namiki,et al.  Number of nodes examined and staging accuracy in colorectal carcinoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  A. Hölscher,et al.  Lymph Node Size and Metastatic Infiltration in Colon Cancer , 1999, Annals of Surgical Oncology.

[14]  A. Giuliano,et al.  Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. , 1999, The American journal of surgical pathology.

[15]  R. Stenling,et al.  Are lymph node micrometastases of any clinical significance in dukes stages A and B colorectal cancer? , 1998, Diseases of the colon and rectum.

[16]  C. V. D. van de Velde,et al.  Micrometastases and survival in stage II colorectal cancer. , 1998, The New England journal of medicine.

[17]  G. Launoy,et al.  Lymph node harvest reporting in patients with carcinoma of the large bowel , 1998, Cancer.

[18]  R. Farouk,et al.  Adjuvant therapy for colorectal cancer. , 1997, Current problems in surgery.

[19]  H. Wieand,et al.  Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  P. Hermanek.  [Lymphadenectomy from the viewpoint of pathology]. , 1996, Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress.

[21]  O. Dent,et al.  Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients , 1994, Cancer.

[22]  D L Morton,et al.  Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.

[23]  N. Petrelli,et al.  Metastases in small lymph nodes from colon cancer. , 1987, Archives of surgery.